I. Kuku Et Al. , "Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma," JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , vol.16, no.3, pp.271-272, 2002
Kuku, I. Et Al. 2002. Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , vol.16, no.3 , 271-272.
Kuku, I., KAYA, E., Sevinc, A., & Aydogdu, I., (2002). Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , vol.16, no.3, 271-272.
Kuku, I Et Al. "Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma," JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , vol.16, no.3, 271-272, 2002
Kuku, I Et Al. "Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma." JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , vol.16, no.3, pp.271-272, 2002
Kuku, I. Et Al. (2002) . "Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma." JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , vol.16, no.3, pp.271-272.
@article{article, author={I Kuku Et Al. }, title={Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma}, journal={JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY}, year=2002, pages={271-272} }